Oncolytic Vaccinia Virus as an Adjuvant Treatment to Cytoreductive Surgery for Malignant Peritoneal Mesothelioma

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

Tristan D. Yan, Marcello Deraco, Dario Baratti et al. · Journal of Clinical Oncology · 2009 · 680 citations · Full text

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

Caroline J. Breitbach, James M. Burke, Derek J. Jonker et al. · Nature · 2011 · 539 citations

Molecular Virology, Viral Pathogenesis, Immunology +6

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

Byeong-Ho Park, Tae-Ho Hwang, Ta‐Chiang Liu et al. · The Lancet Oncology · 2008 · 514 citations

Metastatic Liver Cancer, Hepatology, Medicine +9

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

J. Andrea McCart, Jerrold M. Ward, J. Jack Lee et al. · PubMed · 2001 · 362 citations

Viral Replication, Immunology, Viral Pathogenesis +16

Eradication of Solid Human Breast Tumors in Nude Mice with an Intravenously Injected Light-Emitting Oncolytic Vaccinia Virus

Qian Zhang, Yong Yu, Ena Wang et al. · Cancer Research · 2007 · 229 citations · Full text